Get Premium Data for Cyber Monday: Up to 55% Off InvestingProCLAIM SALE

Implantica AG (IMPsdba)

Stockholm
Currency in SEK
34.35
+0.15(+0.44%)
Closed
IMPsdba Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
33.9534.95
52 wk Range
17.8451.70
Key Statistics
Edit
Prev. Close
34.2
Open
34
Day's Range
33.95-34.95
52 wk Range
17.84-51.7
Volume
30.7K
Average Volume (3m)
26.3K
1-Year Change
74.19%
Book Value / Share
unlockUnlock
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
IMPsdba Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
4.66
Downside
-86.43%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

Implantica AG Company Profile

Implantica AG engages in the research and distribution of medical implants in Switzerland. The company’s lead product candidate is RefluxStop, a passive CE-marked implant for prevention of gastroesophageal reflux disease. It is also involved in the development of eHealth platform, a digital health system to support its pipeline of smart medical implants designed for a safe and secure control and monitoring over the internet; e-InVivo, a sensor implants to monitor a multitude of health parameters and provide diagnostic information, as well as control treatment from inside the body; wireless energizing platform; and AppetiteControl, an implant to treat obesity by controlling appetite. In addition, the company develops UriControl, a remote controlled artificial urinary sphincter to treat urinary incontinence for men and women; and UriRestor, a remote-controlled device that enables spinal cord injury and multiple sclerosis patients to urinate on demand using the wireless platform. Further, it provides PotencyFlow for treatment of erectile dysfunction; StomaRestore for eliminating stoma bags; RectalRestore for treatment of fecal incontinence; and AneurysmControl for the treatment of aneurysms. The company was founded in 2015 and is based in Vaduz, Liechtenstein.

Compare IMPsdba to Peers and Sector

Metrics to compare
IMPsdba
Peers
Sector
Relationship
P/E Ratio
−34.2x−2.7x−0.7x
PEG Ratio
1.41−0.110.00
Price/Book
7.7x2.1x2.6x
Price / LTM Sales
421.1x2.6x3.2x
Upside (Analyst Target)
55.3%24.1%44.1%
Fair Value Upside
Unlock4.8%8.2%Unlock

Analysts' Recommendations

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 53.59

(+56.00% Upside)

FAQ

What Is the Implantica AG (IMPsdba) Stock Price Today?

The Implantica AG stock price today is 34.35

What Stock Exchange Does Implantica AG Trade On?

Implantica AG is listed and trades on the Stockholm stock exchange.

What Is the Stock Symbol for Implantica AG?

The stock symbol for Implantica AG is "IMPsdba."

What Is the Implantica AG Market Cap?

As of today, Implantica AG market cap is 9.72B.

What is Implantica AG Earnings Per Share?

The Implantica AG EPS is -0.087.

From a Technical Analysis Perspective, Is IMPsdba a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.